Cargando…

Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management

Inflammatory bowel disease has an enormous impact on public health, medical systems, economies, and social conditions. Biologic therapy has ameliorated the treatment and clinical course of patients with inflammatory bowel disease. The efficacy and safety profiles of currently available therapies are...

Descripción completa

Detalles Bibliográficos
Autor principal:	M’Koma, Amosy Ephreim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118064/ https://www.ncbi.nlm.nih.gov/pubmed/37089816 http://dx.doi.org/10.18103/mra.v11i1.3135

Ejemplares similares

Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview
por: M’Koma, Amosy Ephreim
Publicado: (2022)

The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview
por: M’Koma, Amosy E.
Publicado: (2019)

Inflammatory Bowel Disease: An Expanding Global Health Problem
por: M’Koma, Amosy E.
Publicado: (2013)

Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood
por: M’Koma, Amosy E., et al.
Publicado: (2023)

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, a By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis
por: Bragg, Maya A., et al.
Publicado: (2023)

Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn’s Colitides
por: Korolkova, Olga Y, et al.
Publicado: (2015)

Letter to Editor
por: M’Koma, Amosy E.
Publicado: (2013)

Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn’s Colitis among Indeterminate Colitis Cohorts
por: Breaux, William A., et al.
Publicado: (2023)

Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis
por: Hawkins, Alexander T, et al.
Publicado: (2017)

Smooth muscle dysfunction in the pre-inflammation site in stenotic Crohn’s-like colitis: implication of mechanical stress in bowel dysfunction in gut inflammation
por: Johnson, John C., et al.
Publicado: (2023)

Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations
por: Herman, AM, et al.
Publicado: (2020)

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
por: Williams, Amanda D., et al.
Publicado: (2017)

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
por: Williams, Amanda D., et al.
Publicado: (2017)

Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease
por: Rana, Tanu, et al.
Publicado: (2021)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

The MYTHS of De novo Crohn’s Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis
por: James, SD, et al.
Publicado: (2020)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Endoscopic evaluation in diagnosis and management of inflammatory bowel disease
por: Moran, Carthage P, et al.
Publicado: (2016)

Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management
por: Bai, Mei, et al.
Publicado: (2023)

Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment
por: Spiceland, Clayton M, et al.
Publicado: (2018)

Advances in the Diagnosis and Management of Inflammatory Bowel Disease: Challenges and Uncertainties
por: Mosli, Mahmoud, et al.
Publicado: (2014)

Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States
por: Al Sulais, Eman, et al.
Publicado: (2021)

Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease
por: Mosli, Mahmoud H., et al.
Publicado: (2022)

Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases
por: Biernacka, Katarzyna B., et al.
Publicado: (2019)

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
por: Axelrad, Jordan E., et al.
Publicado: (2020)

Evaluating the clinical application of the immune cells’ ratios and inflammatory markers in the diagnosis of inflammatory bowel disease
por: Al-Rshaidat, Mamoon M. D., et al.
Publicado: (2023)

Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease
por: Lee, Ji Min, et al.
Publicado: (2016)

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
por: Cury, DB, et al.
Publicado: (2019)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease
por: Sheth, Tejas, et al.
Publicado: (2015)

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
por: Porter, Chad K, et al.
Publicado: (2012)

Diagnosis and treatment of anemia in patients with inflammatory bowel disease
por: Mücke, Victoria, et al.
Publicado: (2017)

New Imaging Techniques in the Diagnosis of Inflammatory Bowel Diseases
por: Li, Yan, et al.
Publicado: (2015)

Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions
por: Schachne, Jonathan M, et al.
Publicado: (2021)

Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease
por: Nigam, Gaurav B., et al.
Publicado: (2018)

Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Del Vecchio, Livio Enrico, et al.
Publicado: (2022)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
por: Prasad, Sharmila S., et al.
Publicado: (2020)

Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease
por: Guo, Yilin, et al.
Publicado: (2018)

Obesity and novel management of inflammatory bowel disease
por: Kim, Jee Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9vvf28h600emmitq18227h8v52